Showing results (931-940 of 952) with videos related to
Sort By:
Pageof 96
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2019
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trialO Trédan, Q Wang, D Pissaloux, et al.Lupus|March 14, 2023
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohortLuis Alonso González, Graciela S Alarcón, Guillermina B Harvey, et al.Annals of the Rheumatic Diseases|February 15, 2014
The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohortManuel F Ugarte-Gil, Eduardo Acevedo-Vásquez, Graciela S Alarcón, et al.Lupus|September 11, 2024
Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patientsGuillermo J Pons-Estel, Rosana Quintana, Manuel F Ugarte-Gil, et al.Lupus|June 4, 2021
Factors associated with neuropsychiatric involvement in Latin American patients with systemic lupus erythematosusLeonor A Barile-Fabris, Hilda Fragoso-Loyo, Daniel Wojdyla, et al.Clinical Rheumatology|May 22, 2019
Correction to: PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A Beltrán, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 24, 2016
PANLAR Consensus Recommendations for the Management in Osteoarthritis of Hand, Hip, and KneeOscar Rillo, Humberto Riera, Carlota Acosta, et al.Clinical Rheumatology|March 28, 2019
PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A B Roa, et al.Eclinicalmedicine|January 8, 2026
Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO groupAnne Quinquenel, Rémi Letestu, Magali Le Garff-Tavernier, et al.Lupus Science & Medicine|July 30, 2025
Item-specific factors associated with damage accrual in systemic lupus erythematosus: insights from a multiethnic, multinational Latin American cohortMilena Mimica, Oslando Padilla, Guillermo Pons-Estel, et al.Pageof 96